“…The critical role of terminal selectors in dictating cell identity has been extensively documented and experimentally verified in various biological settings, including the conversion of fibroblasts to striated muscle cells (Davis et al, 1987), neural and ectoderm specification (Deneris & Hobert, 2014;Dillon et al, 2022;Leon et al, 2022), as well as the prominent involvement of homeodomain TFs (e.g., HOX proteins) in a plethora of biological processes during embryo-and organogenesis, axial and tissue patterning, limb formation and so on (e.g., Bürglin & Affolter, 2016). Many TFs predate the Metazoa in evolutionary origin (e.g., Brunet & King, 2017, 2022de Mendoza & Sebé-Pedrós, 2019;Fairclough et al, 2013;Grau-Bové et al, 2017;López-Escardó et al, 2019;Sebé-Pedrós & de Mendoza, 2015;Sebé-Pedrós et al, 2016) and act deep within primal cell plasticity control mechanisms. It has been demonstrated that forced expression/ activation or repression/disturbance of (sometimes single) key TFs is sufficient to alter cell identity, change cell-fate decisions along the differentiation route or even return the cell to totipotency, a baseline, early blastomere-like state with unrestricted potential to reproduce all cell lineages and give rise to a clonal embryoid (e.g., Amadei et al, 2022;de Silva et al, 2022;DuBuc et al, 2020;Graf & Enver, 2009;Lau et al, 2022;Minnoye et al, 2020;E.…”